CEACAM5 and gastric cancer: Similarly, exosomal lncRNA-GC1 has effectively distinguished gastric cancer patients from controls and related conditions, with AUCs exceeding 0.86, thereby outperforming traditional markers such as CA 72-4, CEA, and CA19-9, which all scored below 0.79.